CTO
Citius Oncology, Inc. (CTOR) Q4 2024 Annual Earnings
CTOR·Reported May 14, 2025·Before market open
Diluted EPS came in at $-0.11, missed the $-0.09 consensus by $0.02.
Diluted EPS
$-0.11missed by $0.02
Consensus: $-0.09
Financial Snapshot
Trailing eight quarters through Q4 2024
Q4 2024 Earnings FAQ
Common questions about Citius Oncology, Inc.'s Q4 2024 earnings report.
Citius Oncology, Inc. (CTOR) reported Q4 2024 earnings on May 14, 2025 before market open.
Citius Oncology, Inc. reported diluted EPS of $-0.11 for Q4 2024.
EPS missed the consensus estimate of $-0.09 by $0.02.
You can read the 10-K/A periodic report (0001213900-25-007012) directly on SEC EDGAR. The filing index links above go to sec.gov.